These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26102320)

  • 1. Primary Care Physicians' Knowledge and Attitudes Regarding Prescription Opioid Abuse and Diversion.
    Hwang CS; Turner LW; Kruszewski SP; Kolodny A; Alexander GC
    Clin J Pain; 2016 Apr; 32(4):279-84. PubMed ID: 26102320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic noncancer pain management in primary care: family medicine physicians' risk assessment of opioid misuse.
    Kavukcu E; Akdeniz M; Avci HH; Altuğ M; Öner M
    Postgrad Med; 2015 Jan; 127(1):22-6. PubMed ID: 25539797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain.
    Setnik B; Roland CL; Pixton GC; Sommerville KW
    Postgrad Med; 2017 Jan; 129(1):5-11. PubMed ID: 27782769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).
    Lin DH; Lucas E; Murimi IB; Jackson K; Baier M; Frattaroli S; Gielen AC; Moyo P; Simoni-Wastila L; Alexander GC
    Addiction; 2017 Feb; 112(2):311-319. PubMed ID: 27658522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.
    Cicero TJ; Ellis MS
    JAMA Psychiatry; 2015 May; 72(5):424-30. PubMed ID: 25760692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicians' beliefs and likelihood of prescribing opioid tamper-resistant formulations for chronic noncancer pain patients.
    Turk DC; Dansie EJ; Wilson HD; Moskovitz B; Kim M
    Pain Med; 2014 Apr; 15(4):625-36. PubMed ID: 24612185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamper-resistant opioid formulations in the treatment of acute pain.
    Passik SD
    Adv Ther; 2014 Mar; 31(3):264-75. PubMed ID: 24526323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers.
    Jamison RN; Sheehan KA; Scanlan E; Matthews M; Ross EL
    J Opioid Manag; 2014; 10(6):375-82. PubMed ID: 25531955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combating an Epidemic of Prescription Opioid Abuse.
    Pon D; Awuah K; Curi D; Okyere E; Stern CS
    J Calif Dent Assoc; 2015 Nov; 43(11):673-8. PubMed ID: 26798885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the impact of abuse-deterrent opioids (ADOs): identifying epidemiologic factors related to new entrants with low population exposure.
    Roland CL; Setnik B; Brown DA
    Postgrad Med; 2017 Jan; 129(1):12-21. PubMed ID: 27960575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid analgesics for pain control: wisconsin physicians' knowledge, beliefs, attitudes, and prescribing practices.
    Wolfert MZ; Gilson AM; Dahl JL; Cleary JF
    Pain Med; 2010 Mar; 11(3):425-34. PubMed ID: 20002590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a Psychological Opioid-Risk Evaluation on Opioid Prescribing in Primary Care.
    Vargovich AM; McNeil DW; Foley KP; Sperry J
    Fam Med; 2016 Jul; 48(7):538-45. PubMed ID: 27472791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. America's Opioid Epidemic: Supply and Demand Considerations.
    Clark DJ; Schumacher MA
    Anesth Analg; 2017 Nov; 125(5):1667-1674. PubMed ID: 29049112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
    Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
    JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting.
    Coplan PM; Chilcoat HD; Butler SF; Sellers EM; Kadakia A; Harikrishnan V; Haddox JD; Dart RC
    Clin Pharmacol Ther; 2016 Sep; 100(3):275-86. PubMed ID: 27170195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access.
    Rutkow L; Turner L; Lucas E; Hwang C; Alexander GC
    Health Aff (Millwood); 2015 Mar; 34(3):484-92. PubMed ID: 25732500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol.
    Degenhardt L; Larance B; Bruno R; Lintzeris N; Ali R; Farrell M
    Addiction; 2015 Feb; 110(2):226-37. PubMed ID: 25358480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids.
    Peacock A; Bruno R; Cama E; Kihas I; Larance B; Lintzeris N; Hordern A; White N; Ali R; Degenhardt L
    Drug Alcohol Rev; 2015 Nov; 34(6):611-22. PubMed ID: 26084592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.